HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jui-Lin Liang Selected Research

Genomic Instability

1/2020Nociceptive transient receptor potential canonical 7 (TRPC7) mediates aging-associated tumorigenesis induced by ultraviolet B.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jui-Lin Liang Research Topics

Disease

2Neoplasm Metastasis (Metastasis)
10/2023 - 12/2017
2Neoplasms (Cancer)
10/2023 - 06/2016
2Carcinogenesis
01/2020 - 12/2017
2Breast Neoplasms (Breast Cancer)
12/2017 - 05/2017
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2023
1Lung Neoplasms (Lung Cancer)
10/2023
1Adenocarcinoma of Lung
03/2023
1Genomic Instability
01/2020
1Triple Negative Breast Neoplasms
12/2017
1Pathologic Complete Response
12/2017
1Esophageal Neoplasms (Esophageal Cancer)
06/2016
1Esophageal Squamous Cell Carcinoma
06/2016
1Cytokine Release Syndrome
01/2016

Drug/Important Bio-Agent (IBA)

3Biomarkers (Surrogate Marker)IBA
10/2023 - 05/2017
1Long Noncoding RNAIBA
10/2023
1CalciumIBA
03/2023
1CarcinogensIBA
01/2020
1MicroRNAs (MicroRNA)IBA
12/2017
1CateninsIBA
12/2017
1Trastuzumab (Herceptin)FDA Link
05/2017
1cyclic 3',5'-thymidine monophosphate (cTMP)IBA
05/2017
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
06/2016
1Indicators and Reagents (Reagents)IBA
06/2016
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2016

Therapy/Procedure

3Therapeutics
12/2017 - 06/2016
1Drug Therapy (Chemotherapy)
12/2017